Does CRIZOTINIB Cause Malignant neoplasm progression? 195 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 195 reports of Malignant neoplasm progression have been filed in association with CRIZOTINIB (Xalkori). This represents 2.0% of all adverse event reports for CRIZOTINIB.
195
Reports of Malignant neoplasm progression with CRIZOTINIB
2.0%
of all CRIZOTINIB reports
53
Deaths
54
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CRIZOTINIB?
Of the 195 reports, 53 (27.2%) resulted in death, 54 (27.7%) required hospitalization, and 10 (5.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CRIZOTINIB. However, 195 reports have been filed with the FAERS database.
What Other Side Effects Does CRIZOTINIB Cause?
Death (2,028)
Neoplasm progression (1,161)
Nausea (820)
Disease progression (677)
Diarrhoea (631)
Vomiting (600)
Fatigue (419)
Off label use (353)
Dyspnoea (352)
Visual impairment (315)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CRIZOTINIB Alternatives Have Lower Malignant neoplasm progression Risk?
CRIZOTINIB vs CROFELEMER
CRIZOTINIB vs CROMOLYN
CRIZOTINIB vs CROTALIDAE POLYVALENT IMMUNE FAB
CRIZOTINIB vs CUBICIN
CRIZOTINIB vs CUPRIC